These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 9889240)

  • 1. Comparison of NucliSens and Roche Monitor assays for quantitation of levels of human immunodeficiency virus type 1 RNA in plasma.
    Dyer JR; Pilcher CD; Shepard R; Schock J; Eron JJ; Fiscus SA
    J Clin Microbiol; 1999 Feb; 37(2):447-9. PubMed ID: 9889240
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multicenter comparison of Roche COBAS AMPLICOR MONITOR version 1.5, Organon Teknika NucliSens QT with Extractor, and Bayer Quantiplex version 3.0 for quantification of human immunodeficiency virus type 1 RNA in plasma.
    Murphy DG; Côté L; Fauvel M; René P; Vincelette J
    J Clin Microbiol; 2000 Nov; 38(11):4034-41. PubMed ID: 11060065
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of three different commercial methods for measuring plasma viraemia in patients infected with non-B HIV-1 subtypes.
    Holguín A; de Mendoza C; Soriano V
    Eur J Clin Microbiol Infect Dis; 1999 Apr; 18(4):256-9. PubMed ID: 10385013
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of two amplification technologies for detection and quantitation of human immunodeficiency virus type 1 RNA in the female genital tract. Division of AIDS Treatment Research Initiative 009 Study Team.
    Bremer J; Nowicki M; Beckner S; Brambilla D; Cronin M; Herman S; Kovacs A; Reichelderfer P
    J Clin Microbiol; 2000 Jul; 38(7):2665-9. PubMed ID: 10878061
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the NucliSens EasyQ HIV-1 v1.1 and RealTime HIV-1 kits for quantitation of HIV-1 RNA in plasma.
    Choi JY; Kim EJ; Rho HJ; Kim JY; Kwon OK; Lee JH; Koo MJ; Kim SS
    J Virol Methods; 2009 Oct; 161(1):7-11. PubMed ID: 19576640
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rates of and reasons for failure of commercial human immunodeficiency virus type 1 viral load assays in Brazil.
    Drexler JF; de Souza Luna LK; Pedroso C; Pedral-Sampaio DB; Queiroz AT; Brites C; Netto EM; Drosten C
    J Clin Microbiol; 2007 Jun; 45(6):2061-3. PubMed ID: 17392448
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Underevaluation of HIV-1 plasma viral load by a commercially available assay in a cluster of patients infected with HIV-1 A/G circulating recombinant form (CRF02).
    Amendola A; Bordi L; Angeletti C; Visco-Comandini U; Abbate I; Cappiello G; Budabbus MA; Eljhawi OA; Mehabresh MI; Girardi E; Antinori A; Ippolito G; Capobianchi MR
    J Acquir Immune Defic Syndr; 2002 Dec; 31(5):488-94. PubMed ID: 12473837
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular-based methods for quantifying HIV viral load.
    Peter JB; Sevall JS
    AIDS Patient Care STDS; 2004 Feb; 18(2):75-9. PubMed ID: 15006182
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of NucliSens and Amplicor monitor assays for quantification of human immunodeficiency virus type 1 (HIV-1) RNA in plasma of persons with HIV-1 subtype A infection in Abidjan, Côte d'Ivoire.
    Nkengasong JN; Kalou M; Maurice C; Bile C; Borget MY; Koblavi S; Boateng E; Sassan-Morokro M; Anatole-Ehounou E; Ghys P; Greenberg AE; Wiktor SZ
    J Clin Microbiol; 1998 Sep; 36(9):2495-8. PubMed ID: 9705381
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of human immunodeficiency virus type 1 (HIV-1) genetic diversity on performance of four commercial viral load assays: LCx HIV RNA Quantitative, AMPLICOR HIV-1 MONITOR v1.5, VERSANT HIV-1 RNA 3.0, and NucliSens HIV-1 QT.
    Swanson P; de Mendoza C; Joshi Y; Golden A; Hodinka RL; Soriano V; Devare SG; Hackett J
    J Clin Microbiol; 2005 Aug; 43(8):3860-8. PubMed ID: 16081923
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitation of human immunodeficiency virus type 1 RNA in different biological compartments.
    Shepard RN; Schock J; Robertson K; Shugars DC; Dyer J; Vernazza P; Hall C; Cohen MS; Fiscus SA
    J Clin Microbiol; 2000 Apr; 38(4):1414-8. PubMed ID: 10747117
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative and cost comparison of ultrasensitive human immunodeficiency virus type 1 RNA viral load assays: Bayer bDNA quantiplex versions 3.0 and 2.0 and Roche PCR Amplicor monitor version 1.5.
    Elbeik T; Charlebois E; Nassos P; Kahn J; Hecht FM; Yajko D; Ng V; Hadley K
    J Clin Microbiol; 2000 Mar; 38(3):1113-20. PubMed ID: 10699005
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ultrasensitive reverse transcription-PCR assay for quantitation of human immunodeficiency virus type 1 RNA in plasma.
    Sun R; Ku J; Jayakar H; Kuo JC; Brambilla D; Herman S; Rosenstraus M; Spadoro J
    J Clin Microbiol; 1998 Oct; 36(10):2964-9. PubMed ID: 9738051
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of levels of human immunodeficiency virus type 1 RNA in plasma as measured by the NucliSens nucleic acid sequence-based amplification and Quantiplex branched-DNA assays.
    Ginocchio CC; Tetali S; Washburn D; Zhang F; Kaplan MH
    J Clin Microbiol; 1999 Apr; 37(4):1210-2. PubMed ID: 10074556
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Initial evaluation of the Roche COBAS TaqMan HIV-1 v2.0 assay for determining viral load in HIV-infected individuals.
    Taylor N; Schmid I; Egle A; Greil R; Patsch W; Oberkofler H
    Antivir Ther; 2009; 14(8):1189-93. PubMed ID: 20032549
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of the Nuclisens HIV-1 QT assay for quantitation of human immunodeficiency virus type 1 RNA levels in plasma.
    Segondy M; Ly TD; Lapeyre M; Montes B
    J Clin Microbiol; 1998 Nov; 36(11):3372-4. PubMed ID: 9774598
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical comparison of branched DNA and reverse transcriptase-PCR and nucleic acid sequence-based amplification assay for the quantitation of circulating recombinant form_BC HIV-1 RNA in plasma.
    Pan P; Tao X; Zhang Q; Xing W; Sun X; Pei L; Jiang Y
    AIDS; 2007 Dec; 21 Suppl 8():S27-32. PubMed ID: 18172387
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of the Abbott m2000rt RealTime HIV-1 assay with manual sample preparation compared with the ROCHE COBAS AmpliPrep/AMPLICOR HIV-1 MONITOR v1.5 using specimens from East Africa.
    Crump JA; Scott LE; Msuya E; Morrissey AB; Kimaro EE; Shao JF; Stevens WS
    J Virol Methods; 2009 Dec; 162(1-2):218-22. PubMed ID: 19729037
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Validation of the NucliSens Extractor combined with the AmpliScreen HIV version 1.5 and HCV version 2.0 test for application in NAT minipool screening.
    Jongerius JM; Sjerps M; Cuijpers HT; van Drimmelen HA; van der Poel CL; Reesink HW; Molijn MH; Peeters GA; Peeters TP; Lelie PN
    Transfusion; 2002 Jun; 42(6):792-7. PubMed ID: 12147034
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative evaluation of the Cobas Amplicor HIV-1 Monitor Ultrasensitive Test, the new Cobas AmpliPrep/Cobas Amplicor HIV-1 Monitor Ultrasensitive Test and the Versant HIV RNA 3.0 assays for quantitation of HIV-1 RNA in plasma samples.
    Berger A; Scherzed L; Stürmer M; Preiser W; Doerr HW; Rabenau HF
    J Clin Virol; 2005 May; 33(1):43-51. PubMed ID: 15797364
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.